(Q35803711)

10 August 2017

Patient reporting of potential adverse drug reactions: a methodological study (English)

1 reference

10 August 2017

1 reference

N Jarernsiripornkul

1

1 reference

10 August 2017

J Krska

2

1 reference

10 August 2017

P A G Capps

3

1 reference

10 August 2017

R M E Richards

4

1 reference

10 August 2017

A Lee

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

53

1 reference

10 August 2017

3

1 reference

10 August 2017

318-325

1 reference

Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Analysis of adverse effects among patients with essential hypertension receiving an ACE inhibitor or a beta-blocker.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Drug-related hospital admissions

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Side effects of chronic lithium therapy in Hong Kong Chinese: an ethnopsychiatric perspective

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Patient drug attributions and postmarketing surveillance.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Postmarketing surveillance by patient self-monitoring: preliminary data for sertraline versus fluoxetine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Approaching a century and after: morbidity and potentially drug induced disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Side reactions in neurotics. I. A comparison of two methods of assessment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Patient-perceived side effects to antihypertensive drugs.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Physician Knowledge, Attitudes, and Behavior Related to Reporting Adverse Drug Events

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Involving the patient in reporting adverse drug reactions

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Spontaneous reporting of adverse drug reactions. II: Uses

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Patients as a direct source of information on adverse drug reactions

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Postmarketing surveillance of adverse drug reactions: patient self-monitoring

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Development of a questionnaire for detecting potential adverse drug reactions

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Attitudes to adverse drug reaction reporting in the Northern Region

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

A Methodological Study of Some Factors Influencing the Reporting of Symptoms

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Post-marketing surveillance of adverse reactions to new medicines

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874308

Adverse drug reactions: Can consumers provide early warning?

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.0306-5251.2001.01547.X

Detection of adverse drug reactions in a clinical trial using two types of questioning

21 January 2018

1 reference

12 December 2020

Patients' experiences of chemotherapy: side-effects of carboplatin in the treatment of carcinoma of the ovary

1 reference

12 December 2020

Patient-initiated postmarketing surveillance: a validation study

1 reference

12 December 2020

Postmarketing surveillance: accuracy of patient drug attribution judgments

1 reference

12 December 2020

Evaluating drugs after their approval for clinical use

1 reference

12 December 2020

Experience in the development of a postmarketing surveillance network: the pharmacy medication monitoring program

1 reference

12 December 2020

1 reference

12 December 2020

Side reactions in neurotics: II. Can patients judge which symptoms are caused by their medication?

1 reference

12 December 2020

Knowledge of and Attitudes About Adverse Drug Reaction Reporting Among Rhode Island Pharmacists

1 reference

12 December 2020

Safety reporting in clinical trials

1 reference

12 December 2020

Prescriber profile and post-marketing surveillance

1 reference

12 December 2020

Rhode Island physicians' recognition and reporting of adverse drug reactions

1 reference

12 December 2020

Adverse drug reaction reporting in a multicenter surveillance study

1 reference

12 December 2020

Time to act on drug safety

1 reference

12 December 2020

Side effects of CHOP in the treatment of non-hodgkin's lymphoma

1 reference

12 December 2020

Regulatory pharmacovigilance in the United Kingdom: current principles and practice

1 reference

12 December 2020

10.1046/J.0306-5251.2001.01547.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

11874396

1 reference